Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Lux: Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions. (0.08 sec) 

Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?

- prsjournal.com
S Bopp - British Journal of Ophthalmology, 2007 - bjo.bmj.com
In the era of anti-vascular endothelial growth factor (VEGF) therapy for
exudative age-related macular degeneration (ARMD), a paradigm shift has emerged.
Until then, photodynamic therapy (PDT) was considered a successful ...
Cited by 3 - Related articles - BL Direct - All 5 versions

Off-Label Use of Bevacizumab for the Treatment of Age-Related Macular Degeneration: …

- prsjournal.com
F Ziemssen, S Grisanti, KU Bartz-Schmidt, MS … - Drugs &# 38; Aging, 2009 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . 295 1. Approved Indications of Bevacizumab. . . . . . . . . . . . ...
Cited by 1 - Related articles - All 7 versions

Surgical management of subfoveal choroidal neovascular membranes in age-related macular …


AM Joussen, D Wong, P Walter, B Kirchhof, J … - Eye, 2009 - nature.com
Patients suffering from visual loss because of AMD were randomised to either
surgery or a control group receiving standard treatment (observation or
photodynamic therapy (PDT)). The primary end point was the change of visual ...
Related articles - All 3 versions

Refractory Neovascular Age-related Macular Degeneration Secondary to Polypoidal …


M Cho, IA Barbazetto, KB Freund - American Journal of Ophthalmology, 2009 - Elsevier
Despite success in the majority of patients enrolled in the MARINA and ANCHOR
trials, there was still a minority of patients who continued to lose vision
despite treatment. In addition, some patients who initially experienced ...
Related articles - All 24 versions

Surgical choroidal neovascular membrane removal in the era of anti-vascular endothelial …


M Nagpal, K Nagpal, V Mehta - Indian Journal of Ophthalmology, 2009 - pubmedcentral.nih.gov
The efficacy of intravitreal anti-vascular endothelial growth factor (VEGF)
agents for treatment of choroidal neovascular membranes (CNVMs) of varying
etiologies as the first line of treatment, has been adequately proven by ...
Related articles - All 4 versions

Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions

- prsjournal.com [PDF] 
N Nigam, J Hedaya, WR Freeman - British Medical Journal, 2008 - bjo.bmj.com
LB Cantor Correspondence to: LB Cantor, Department of Ophthalmology, Indiana
University School of Medicine, Indianapolis, IN 46202, USA; lcantor@iupui.edu
Funding: Supported in part by an unrestricted research grant from the ...
Related articles - All 5 versions

Bevacizumab Tachyphylaxis


KG Falavarjani, M Modarres - Ophthalmology, 2009 - Elsevier
Schaal et al 1 reported the biologic effectiveness of the injections based on a
standardized volumetric change index determined from OCT measurement of retinal
thickness, but they did not report the amount of each thickness ...
Related articles - All 16 versions

Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular …


KE Schmid-Kubista, I Krebs, B Gruenberger, F … - British Medical Journal, 2009 - bjo.bmj.com
Methods: Subjects with fibrovascular pigment epithelial detachment, subfoveal
choroidal neovascularisation extending under the geometric centre of the foveal
avascular zone and/or macular thickness of at least 300 µm in both eyes ...
Related articles - All 7 versions

Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of …


S Jyothi, H Chowdhury, M Elagouz, S … - Eye, 2009 - nature.com
The current medical environment demands that quality health care is delivered at
an affordable cost through the use of objective, unbiased clinical data. This
study was undertaken to review the current literature on bevacizumab for ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google